Bacterial Lipopolysaccharides Induce Peripheral Nerve Disturbances in Rats That Mimic Human Immune-Mediated Polyneuropathies

Laboratory Animal Science

Volumn 47, Issue 4, 1997, Pages 354-361

  Brown, Rhonda F ^a,b   Jackson, Graham D F ^a   Martin, Thomas ^a   Westbrook, R Fred ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL FEATURE; DISEASE MODEL; ESCHERICHIA COLI; GAIT DISORDER; HOT PLATE TEST; MALE; MUSCLE WEAKNESS; NONHUMAN; POLYNEUROPATHY; PROPRIOCEPTION; RAT; TAIL FLICK TEST;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SEX CHARACTERISTICS; SPECIES SPECIFICITY;

EID: 0031402889     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Martin, T., and R. F. Brown. 1994. Unexpected response to endotoxin in inbred SPF Wistar (AaW) rats, p. 50-53. In Total quality: animals and research. Proc. of the 18th Conf. of the Australian Soc. for Lab. Anim. Sci.
2. Brown, R. F., and M. Kiernan. 1995. Bacterial endotoxins induce neurological symptoms in adult male Wistar rats. Soc. Neurosci. Abs. 2124.
3. Kurtz, H. J., and J. Quast. 1982. Effects of continuous intravenous infusion of Escherichia coli endotoxin into swine. Am. J. Vet. Res. 43:262-268.
4. Ornoy, A., and G. Altshuler. 1975. Maternal endotoxemia, fetal anomalies, and central nervous system damage: a rat model of a human problem. Am. J. Obstet. Gynecol. 124:196-204.
5. Gilles, F. H., A. Leviton, and C. S. Kerr. 1976. Endotoxin leukoencephalopathy in the telencephalon of the newborn kitten. J. Neurol. Sci. 27:183-191.
6. Gilles, F. H., D. R. Averill, and C. S. Kerr. 1977. Neonatal endotoxin encephalopathy. Ann. Neurol. 2:49-56.
7. Winer, J. B., R. A. C. Hughes, M. J. Anderson, et al. 1988. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J. Neurol. Neurosurg. Psychiatry 51:613-618.
8. Kuroki, S., T. Saida, M. Nukina, et al. 1993. Campylobacter jejuni strains from patients with Guillain Barré syndrome belong mostly to Penner serogroup 19 and contain b-N-acetylglucosamine residues. Ann. Neurol. 33:243-247.
9. Zochodne, D. W., C. F. Bolton, G. A. Wells, et al. 1987. Critical illness polyneuropathy: a complication of sepsis and multiorgan failure. Brain 110:819-842.
10. Witt, N. J., D. W. Zochodne, and C. F. Bolton. 1991. Peripheral nerve function in sepsis and multiple organ failure. Chest 99:176-184.
11. Bolton, C. F. 1993. Neuromuscular complications of sepsis. Intensive Care Med. 19:S58-S63.
12. Yuki, N., T. Taki, F. Inagaki, et al. 1993. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178:1771-1775.
13. Wirguin, I., G. Rosoklija, W. Trojaborg, et al. 1995. Axonal degeneration accompanied by conduction block induced by toxin mediated immune reactivity to GM1 ganglioside in rat nerves. J. Neurol. Sci. 130:17-21.
14. Rees, J. H., N. A. Gregson, P. L. Griffiths, et al. 1993. Campylobacter jejuni and Guillain Barré syndrome. Q. J. Med. 86:623-634.
15. Tjolsen, A., A. Lund, O. Berge, et al. 1989. An improved method for tail-flick testing with adjustment for tail-skin temperature. J. Neurosci. Methods 26:259-265.
16. Kawakita, K., and M. Funakoshi. 1987. A quantitative study on the tail flick test in the rat. Physiol. Behav. 39:235-240.
17. Westbrook, R. F., J. D. Greeley, C. P. Nabke, et al. 1991 Aversive conditioning in the rat: effects of a benzodiazepine and of an opioid agonist and antagonist on conditioned hypoalgesia and fear. J. Exp. Psychol. Anim. Behav. Process. 17:219-230.
18. Lindsey, J. R. 1979. Historical foundations, p. 2-33. In H. J. Baker, J. R. Lindsey, and S. H. Weisbroth (ed.), The laboratory rat: biology and diseases, vol. 1. Academic Press, New York.
19. D'Amour, F. E., and D. L. Smith. 1941. Amethod for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:74-79.
20. Chrisman, C. L. 1991. The physical and neurologic examinations, p. 41-72. Problems in small animal neurology, 2nd ed. Lea & Febiger, Philadelphia.
21. Thalhammer, J. G., M. Vladimirova, B. Bershadsky, et al. 1995. Neurologic evaluation of the rat during sciatic nerve block with lidocaine. Anesthesiology 82:1013-1025.
22. Festing, M. F. W. 1979. Inbred strains, p. 55-72. In H. J. Baker, J. R. Lindsay, and S. H. Weisbroth, (ed.), The laboratory rat: biology and diseases, vol. 1. Academic Press, New York.
23. Pollard, J. D. 1993. Immunopathology of Guillain Barré syndrome, p. 146-163. In G. J. Parry (ed.), Guillain Barré syndrome. Thieme Medical Publishers, New York.
24. Frederic, F., C. Oliver, E. Wollman, et al. 1993. IL-1 and LPS induce a sexually dimorphic response of the hypothalamo-pituitary-adrenal axis in several mouse strains. Eur. Cytokine Netw. 4:321-329.
25. Spinedi, E., M. O. Suescun, R. Hadid, et al. 1992. Effects of gonadectomy and sex hormone therapy on the endotoxinstimulated hypothalamo-pituitary-adrenal axis: evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 131:2430-2436.
26. Murakami, N., and T. Ono. 1987. Sex-related differences in fever development of rats. Am. J. Physiol. 252:R284-R289.
27. Adams, R. D., and J. B. Martin. 1984. Acute and chronic pain: pathophysiology and management, p. 7-15. In R. G. Petersdorf, R. D. Adams, E. Braunwald, et al. (ed.), Harrison's principles of internal medicine, 10th ed. McGraw-Hill International Book Co., Tokyo.
28. Wiertelak, E. P., K. Mooney-Heiberger, W. Van Wyhe, et al. 1992. Internal aversive stimuli elicit acute and conditioned hyperalgesia. Soc. Neurosci. Abstr. 18:1026.
29. Watkins, L. R., E. P. Wiertelak, L. E. Goehler, et al. 1994. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 639:283-299.
30. Gitter, B. D., D. Regoli, J. J. Howbert, et al. 1994. Interleukin-6 secretion from human astrocytoma cells induced by substance P. J. Neuroimmunol. 51:101-108.
31. Delrue, C., B. Deleplanque, F. Rouge-Pont, et al. 1994. Brain monoaminergic, neuroendocrine, and immune responses to an immune challenge in relation to brain and behavioral lateralization. Brain Behav. Immun. 8:137-152.
32. Follenfant, R. L., M. Nakamura-Craig, B. Henderson, et al. 1989. Inhibition by neuropeptides of interleukin-1b-induced, prostaglandin-independent hyperalgesia. Br. J. Pharmacol. 98:41-43.
33. Cunha, F. Q., B. B. Lorenzetti, S. Poole, et al. 1991. Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol. 104:765-767.
34. Brown, R. F., and T. Martin. 1994. The neurological effects of bacterial endotoxins, p. 53-55. In Total quality: animals and research. Proc. of the 18th Conf. of the Australian Soc. for Lab. Anim. Sci.
35. Hardonk, M. J., F. W. J. Dijkhuis, C. E. Hulstaert, et al. 1992. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J. Leukoc. Biol. 52:296-302.
36. Iimuro, Y., M. Yamamoto, H. Kohno, et al. 1994. Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats: analysis of mechanisms of lethality in endotoxemia. J. Leukoc. Biol. 55:723-728.
37. Roland, C. R., M. J. Mangino, and M. W. Flye. 1993. Lanthanide "blockade" of antigen-presenting cells suppresses lymphocyte proliferation by inducing nitric oxide synthesis. J. Surg. Res. 54:401-410.
38. Decker, K. 1990. Biologically active products of stimulated liver macrophages (kupffer cells). Eur. J. Biochem. 192:245-261.
39. Ghezzi, P., and J. D. Sipe. 1988. Dexamethasone modulation of LPS, IL-1, and TNF stimulated serum amyloid A synthesis in mice. Lymphokine Res. 7:157-166.
40. Hirata, F., D. Schiffman, K. Venkatasubramanian, et al. 1980. Phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc. Natl. Acad. Sci. USA 77:2533-2536.
41. Lin, G., A. E. Pearson, R. W. Scamurra, et al. 1994. Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial lipopolysaccharide. J. Biol. Chem. 269:77-85.
42. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319-326.
43. Radomski, M. W., R. M. J. Palmer, and S. Moncada. 1990. Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 87:10043-10047.
44. Schultz, R. M., S. K. Nanda, and M. G. Altom. 1985 Effects of various inhibitors of arachidonic acid oxygenation on macrophage Superoxide release and tumoricidal activity. J. Immunol. 135:2040-2044.
45. Wahl, S. M., and L. M. Wahl. 1985. Regulation of macrophage collagenase, prostaglandin, and fibroblast-activating factor production by anti-inflammatory agents: different regulatory mechanisms for tissue injury and repair. Cell. Immunol. 92:302-312.
46. Bishop, G. H. 1960. The relation of nerve fiber size to modality of sensation, p. 88-98. In W. Montagna (ed.), Advances in biology of skin, vol. 1. Pergamon Press, London.
47. Winer, J. B., R. A. C. Hughes, and C. Osmond. 1988. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J. Neurol. Neurosurg. Psychiatry 51:605-612.
48. Parry, G. J. 1993. Guillain-Barré Syndrome. Thieme Medical Publishers, New York.
49. Garcia, G. A., M. J. Lopez, and D. R.Aparicio. 1991. Peripheral polyneuropathy complicating conditions of sepsis and multiorgan failure. Electromyogr. Clin. Neurophysiol. 31:181-186.
50. Pourmand, R. 1995. Acquired respiratory failure in critically ill patients. Indiana Med. 88:68-70.